Short Summary
Google and Pointwise Ventures have settled their dispute over U.S. Patent 8,471,812 and jointly moved to terminate the pending IPR. The Board is asked to end the proceeding at this early stage.
Detailed Summary
In a joint motion filed on August 1, 2025, Google LLC and Pointwise Ventures LLC request the Patent Trial and Appeal Board terminate Inter Partes Review IPR2025-01102 covering U.S. Patent No. 8,471,812. The parties state that they have settled the underlying patent dispute, including related district‑court litigation (case No. 6:24‑cv‑00293‑RP), and that no further litigation is anticipated. Citing good cause, they argue that termination at this early stage—where only the petition has been filed—promotes judicial economy and serves their mutual interests. A copy of the settlement agreement will be filed as Exhibit 1016.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Google LLC vs POINTWISE VENTURES, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Multi-Color CorporationvsBrook & Whittle Ltd.
Multi-Color Corp. has filed a post‑grant review petition seeking cancellation of Brook & Whittle’s recyclable shrink‑label patent, alleging anticipation, obviousness, and indefiniteness.
Berkshire Hathaway Energy Company et al.vsMES, Inc.
Berkshire Hathaway Energy and its affiliates have filed an IPR petition challenging 29 claims of a mercury‑removal patent, arguing obviousness and lack of priority support. The petition relies on prior art from early‑2000s conference papers and patents. Institution of the proceeding is pending.
Samsung Electronics Co. Ltd et al.vsMaxell, Ltd.
Samsung opposes Maxell’s request to overturn the PTAB’s final written decision, asserting no inconsistency in expert testimony and accusing Maxell of strategic gamesmanship. The Board’s earlier findings remain unchallenged.
Quotient Technology, LLC et al.vsIntelligent Clearing Network Inc. et al.
The PTAB denied institution of IPR for Quotient Technology against Intelligent Clearing Network regarding patent 10846729. The Board found the Petitioner failed to demonstrate a reasonable likelihood of prevailing on obviousness grounds over prior art references like Aggarwal and Deaton.
Abbott Diabetes Care Inc. et al.vsDexCom, Inc.
Abbott Diabetes Care Inc.'s IPR challenge against DexCom's glucose monitoring patent was instituted by the PTAB. The Board found a reasonable likelihood of success on anticipation and obviousness grounds over prior art reference Gross, despite acknowledging examination complexity. This decision advances Abbott's efforts to invalidate key claims in the medical device space.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.